Orient Pharma Co., Ltd. 4166.TWO Stock
Orient Pharma Co., Ltd. Price Chart
Orient Pharma Co., Ltd. 4166.TWO Financial and Trading Overview
| Orient Pharma Co., Ltd. stock price | 22.7 TWD |
| Previous Close | 23.75 TWD |
| Open | 23.9 TWD |
| Bid | 23.9 TWD x 0 |
| Ask | 24.1 TWD x 0 |
| Day's Range | 23.9 - 24.4 TWD |
| 52 Week Range | 17.85 - 25.25 TWD |
| Volume | 210.39K TWD |
| Avg. Volume | 62.75K TWD |
| Market Cap | 4.62B TWD |
| Beta (5Y Monthly) | 0.204109 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.1 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4166.TWO Valuation Measures
| Enterprise Value | 4.83B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.034386 |
| Price/Book (mrq) | 4.1352096 |
| Enterprise Value/Revenue | 9.443 |
| Enterprise Value/EBITDA | 388.861 |
Trading Information
Orient Pharma Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.204109 |
| 52-Week Change | 23.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25.25 TWD |
| 52 Week Low | 17.85 TWD |
| 50-Day Moving Average | 22.35 TWD |
| 200-Day Moving Average | 21.59 TWD |
4166.TWO Share Statistics
| Avg. Volume (3 month) | 62.75K TWD |
| Avg. Daily Volume (10-Days) | 89.25K TWD |
| Shares Outstanding | 187M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -5.61% |
| Operating Margin (ttm) | -8.15% |
| Gross Margin | 30.34% |
| EBITDA Margin | 2.42% |
Management Effectiveness
| Return on Assets (ttm) | -1.44% |
| Return on Equity (ttm) | -2.60% |
Income Statement
| Revenue (ttm) | 511.86M TWD |
| Revenue Per Share (ttm) | 2.74 TWD |
| Quarterly Revenue Growth (yoy) | -22.90% |
| Gross Profit (ttm) | 155.35M TWD |
| EBITDA | 12.43M TWD |
| Net Income Avi to Common (ttm) | -28759000 TWD |
| Diluted EPS (ttm) | -0.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 97.23M TWD |
| Total Cash Per Share (mrq) | 0.52 TWD |
| Total Debt (mrq) | 508.15M TWD |
| Total Debt/Equity (mrq) | 46.62 TWD |
| Current Ratio (mrq) | 1.205 |
| Book Value Per Share (mrq) | 5.828 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 11.38M TWD |
| Levered Free Cash Flow (ttm) | -11170750 TWD |
Profile of Orient Pharma Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 368, Fu Hsing South Road |
| ZIP | 106 |
| Phone | 886 2 2325 7621 |
| Website | https://www.oppharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Orient Pharma Co., Ltd. researches, develops, manufactures, and sells drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Q&A For Orient Pharma Co., Ltd. Stock
What is a current 4166.TWO stock price?
Orient Pharma Co., Ltd. 4166.TWO stock price today per share is 22.7 TWD.
How to purchase Orient Pharma Co., Ltd. stock?
You can buy 4166.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Orient Pharma Co., Ltd.?
The stock symbol or ticker of Orient Pharma Co., Ltd. is 4166.TWO.
Which industry does the Orient Pharma Co., Ltd. company belong to?
The Orient Pharma Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Orient Pharma Co., Ltd. have in circulation?
The max supply of Orient Pharma Co., Ltd. shares is 223.04M.
What is Orient Pharma Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Orient Pharma Co., Ltd. PE Ratio is 227.00000000 now.
What was Orient Pharma Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Orient Pharma Co., Ltd. EPS is 0.1 TWD over the trailing 12 months.
Which sector does the Orient Pharma Co., Ltd. company belong to?
The Orient Pharma Co., Ltd. sector is Healthcare.